The Future of Generative AI

In the early stage drug discovery, usually you have to validate experimentally anyway in order for the regulators to give you the green light. So generative is not going to change much because access to your platform, usually people have to apply. It's only available to big pharma and they are not in the business of making bad things happen to humanity. On the clinical and clinical study levels now, I don't think you are going to experience any problems we just need to ensure that the doctors do not also rely on generative systems when filing their reports.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app